Behçet's disease;Maladie de Behçet

Revue du Praticien

Volumn 55, Issue 3, 2005, Pages 239-246

  Wechsler, Bertrand ^b   Du Boutin, Lê Thi Huong ^b   Amoura, Zahir ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANTICOAGULANT AGENT; ANTIVITAMIN K; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; HEPARIN; HLA B51 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PENTOXIFYLLINE; THALIDOMIDE;

APHTHOUS ULCER; BEHCET DISEASE; CLINICAL FEATURE; GENITAL ULCER; HUMAN; KIDNEY DISEASE; LATERAL SINUS THROMBOSIS; NEUROLOGICAL COMPLICATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT EDUCATION; PLASMAPHERESIS; REVIEW; THROMBOPHLEBITIS; TREATMENT PLANNING; UVEITIS; VASCULITIS; VEIN THROMBOSIS;

BEHCET SYNDROME; HUMANS;

EID: 14144249136     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Anonymous. International study group for Behçet's disease. Criteria tor diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
2. Yurdakul S, Gunaydin I, Tuzun Y et al. The prevalence of Behçet's syndrome in a rural area in nothern turkey. J Rheumatol 1988; 15: 820-2.
3. Chamberlain MA. Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis 1977; 36: 491-9.
4. Gonzalez-Gay MA, Garcia-Porrua C, Branas F, Lopez-Lazaro L, Olivieri I. Epidemiologic and clinical aspects of Behçet's disease in a defined area of Northwestern Spain, 1988-1997. J Rheumatol 2000; 27: 703-7.
5. Sakane T, Takeno N, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 1999; 341: 1284-91.
6. Koné Paut I. Maladie de Behçet: aspects pédiatriques. Ann Med Interne 1999; 150: 571-5.
7. Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B. Review of the chronology of clinical manifestations in 60 patients with Behcet's disease. Dermatology 2003; 207: 354-6.
8. Narikawa S, Suzuki Y, Takahashi M, Furukawa A, Sakane T, Mizushima Y. Streptococcus oralis previously identified as uncommon "Streptococcus sanguis" in Behcet's disease. Archiv Oral Biol 1995; 40: 685-90.
9. Yurdakul S, Namuryudan V, Yazici H. Behçet's syndrome. Curr Opin Rheumatol 2003; 16: 38-42.
10. Francès C. Manifestations cutanéo-muqueuses de la maladie de Behçet. Ann Med Interne 1999; 150: 535-41.
11. Cassoux N, Fardeau C, LeHoang P. Manifestations oculaires de la maladie de Behçet. Ann Med Interne 1999; 150: 529-34.
12. Cochereau-Massin I, Wechsler B, LeHoang P et al. Pronostic oculaire de la Maladie de Behçet. J Fr Ophtalmol 1992; 15: 343-7.
13. Serdaroglu P, Yazici H, Ozdemir C, Yurdakul S, Bahar S, Atkin E. Neurologic involvement in Behçet's syndrome. A prospective study. Arch Neurol 1989; 46: 265-9.
14. Wechsler B, Sbä A, Boutin LTH, Duhaut P, Dormont D, Piette JC. Complications neurologiques de la maladie de Behçet. Rev Neurol 2002; 158: 926-33.
15. Kidd D, Steuer A, Denman All, Rudge P. Neurological complications in Behçet's syndrome. Brain 1999; 122: 2183-94.
16. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. Brain 1999; 122: 2171-82.
17. Wechsler B, Lê Thi Huong D, Kieffer E. Manifestations cardio-vasculaires de la maladie de Behçet. Ann Med Interne 1999; 150: 542-54.
18. Tohmé A, Aoun N, El-Rassi B, Ghayad E. Vascular manifestations of Behçet's disease: eighteen cases among 140 patients. Joint Bone Spine 2003; 70: 384-9.
19. Blétry O, Mohattane A, Wechsler B et al. Atteinte cardiaque de la maladie de Behçet: douze observations. Presse Med 1988; 17: 2388-91.
20. Ben Taarit C, Turki S, Ben Maïz N. Les manifestations rhumatologiques de la maladie de Behçet: à propos de 309 cas. Rev Med Interne 2001; 22: 1049-55.
21. Kim HA, Choi KW, Song YW. Arthropathy in Behçet's disease. Scand J Rheumatol 1997; 26: 125-9.
22. Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S. Renal Behcet's disease: a cumulative analysis. Semin Arthritis Rheum 2002; 31: 317-37.
23. Wechsler B, Bodaghi B, Lê Thi Huong D et al. Efficacy of interferon α-2a in severe and refractory uveitis associated with Behçet's disease. Ocul Immunol Inflamm 2000; 8: 293-301.
24. Kotter I, Gunaydin I, Zierhut K, Stubiger H. The use of interferon alpha in Behçet's disease: review of the literature. Semin Arthritis Rheum 2004; 33: 320-35.
25. Wechsler B, Sablé-Fourtassou R, Bodaghi B et al. Infliximab in refractory uveitis due to Behçet's disease. Clin Exp Rheumatol 2004; 22 (Suppl.34): S14-S16
26. Yurdakul S, Mat C, Tuzun Y et al. A double-blind trial of colchicine in Behçet's syndrome. Arthritis Rheum 2001; 44: 26-86-92.
27. Vignes S, Vidailhet M, Dormont D, Soulié J, Wechsler B. Présentation pseudotumorale de neuro-Behçet: rôle de l'arrêt de la colchicine? Rev Med Interne 1998; 19: 55-9.
28. Hamuryudan V, Mat C, Saip S et al. Thalidomide in the treatment of the mucocutaneous lesions of the Behçet syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998; 128: 443-50.
29. Yasui K, Ohta K, Kobayashi M, Aizana T, Komiyama A. Successful treatment of Behçet's disease with pentoxifylline. Ann Intern Med 1996; 124: 891-3.